Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review).

Abstract:

:Targeted cancer therapies are used to inhibit the growth, progression, and metastasis of the tumor by interfering with specific molecular targets and are currently the focus of anticancer drug development. Protein kinase B, also known as Akt, plays a central role in many types of cancer and has been validated as a therapeutic target nearly two decades ago. This review summarizes the intracellular functions of Akt as a pivotal point of converging signaling pathways involved in cell growth, proliferation, apoptotis and neo‑angiogenesis, and focuses on the drug design strategies to develop potent anticancer agents targeting Akt. The discovery process of Akt inhibitors has evolved from adenosine triphosphate (ATP)‑competitive agents to alternative approaches employing allosteric sites in order to overcome the high degree of structural similarity between Akt isoforms in the catalytic domain, and considerable structural analogy to the AGC kinase family. This process has led to the discovery of inhibitors with greater specificity, reduced side-effects and lower toxicity. A second generation of Akt has inhibitors emerged by incorporating a chemically reactive Michael acceptor template to target the nucleophile cysteines in the catalytic activation loop. The review outlines the development of several promising drug candidates emphasizing the importance of each chemical scaffold. We explore the pipeline of Akt inhibitors and their preclinical and clinical examination status, presenting the potential clinical application of these agents as a monotherapy or in combination with ionizing radiation, other targeted therapies, or chemotherapy.

journal_name

Int J Oncol

authors

Nitulescu GM,Margina D,Juzenas P,Peng Q,Olaru OT,Saloustros E,Fenga C,Spandidos DΑ,Libra M,Tsatsakis AM

doi

10.3892/ijo.2015.3306

subject

Has Abstract

pub_date

2016-03-01 00:00:00

pages

869-85

issue

3

eissn

1019-6439

issn

1791-2423

journal_volume

48

pub_type

杂志文章,评审
  • Application of RT-PCR to clinical diagnosis of micrometastasis of colorectal cancer: A translational research study.

    abstract::We previously reported in a retrospective study that CEA-based RT-PCR was useful for predicting the prognosis of patients with node-negative colorectal cancer. RT-PCR is well established for laboratory use, but many issues remain to be resolved prior to its clinical application. In addition to the false positive rate ...

    journal_title:International journal of oncology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Takayama O,Yamamoto H,Ikeda K,Ishida H,Kato T,Okuyama M,Kanou T,Fukunaga M,Tominaga S,Morita S,Fujie Y,Fukunaga H,Ikenaga M,Ikeda M,Ohue M,Sekimoto M,Kikkawa N,Monden M

    更新日期:2004-09-01 00:00:00

  • Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax.

    abstract::Pancreatic cancer is one of the most aggressive solid malignancies with a dismal survival rate. Recent studies have shown that high expression levels of histone deacetylase 3 (HDAC3) correlate with malignant phenotype. However, the expression patterns and biological role of HDAC3 in pancreatic cancer remain unclear. I...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2568

    authors: Jiao F,Hu H,Yuan C,Jin Z,Guo Z,Wang L,Wang L

    更新日期:2014-10-01 00:00:00

  • STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.

    abstract::The development of clinical agents remains a costly and time-consuming process. Although identification of new uses of existing drugs has been recognized as a more efficient approach for drug discovery than development of novel drugs, little screening of drugs that might be used for a rare malignant tumor such as oste...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3757

    authors: Oi T,Asanuma K,Matsumine A,Matsubara T,Nakamura T,Iino T,Asanuma Y,Goto M,Okuno K,Kakimoto T,Yada Y,Sudo A

    更新日期:2016-12-01 00:00:00

  • Mutations and differential expression of the ras family genes in human nasal polyposis.

    abstract::Although it is well established that ras genes contribute to tumourigenesis either through the accumulation of mutations or by aberrant expression in a wide range of human cancers, little is known regarding their involvement in human nasal polyps (NPs). In the present study, the occurrence of mutations in codons 11 an...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Zaravinos A,Bizakis J,Soufla G,Sourvinos G,Spandidos DA

    更新日期:2007-11-01 00:00:00

  • Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer.

    abstract::Patients with pancreatic cancer frequently demonstrate symptoms such as weight-loss and muscle wasting and have clinical evidence of a systemic inflammatory response. Such effects may be mediated by pro-inflammatory cytokines derived from tumor cells. The production of interleukin-6 and -8 by pancreatic cancer cell li...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.21.4.881

    authors: Wigmore SJ,Fearon KC,Sangster K,Maingay JP,Garden OJ,Ross JA

    更新日期:2002-10-01 00:00:00

  • The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma.

    abstract::The poor prognosis of Ewing's sarcoma (EWS), together with its high lethal recurrence rate and the side‑effects of current treatments, call for novel targeted therapies with greater curative effectiveness and substantially reduced side‑effects. The oncogenic chimeric protein EWS/FLI1 is the key malignancy driver in mo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.2016

    authors: Sengupta A,Rahman M,Mateo-Lozano S,Tirado OM,Notario V

    更新日期:2013-09-01 00:00:00

  • A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).

    abstract::Although only less than 10% of women with primary breast cancer have clinicopathologic signs of overt metastases, metastatic relapse occurs in about half of the cases with apparently localized tumors within five years after surgery. In 23% of the patients, bone marrow metastases are detectable at first relapse and thi...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.20.5.1027

    authors: Kasimir-Bauer S,Oberhoff C,Schindler AE,Seeber S

    更新日期:2002-05-01 00:00:00

  • Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.

    abstract::This study examines the role of LEF1, a component of the Wnt signaling pathway, in human breast and murine mammary carcinoma and its relationship to ErbB2 (her-2/neu) expression. Mammary tissue and tumors from 5 different Wnt pathway-activated transgenic mouse strains and 5 different ErbB2 pathway-activated transgenic...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Nguyen A,Rosner A,Milovanovic T,Hope C,Planutis K,Saha B,Chaiwun B,Lin F,Imam SA,Marsh JL,Holcombe RF

    更新日期:2005-10-01 00:00:00

  • A phase III randomized study comparing oral doxifluridine and oral 5-fluorouracil after curative resection of gastric cancer.

    abstract::To investigate the usefulness of oral doxifluridine (5'-DFUR), an active intermediate metabolite of capecitabine (XELODA), in gastric cancer patients after curative resection, we conducted a phase III randomized controlled study to compare oral 5'-DFUR and oral 5-fluorouracil (5-FU). 485 gastric cancer patients with S...

    journal_title:International journal of oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.3892/ijo.16.5.1021

    authors: Takiguchi N,Nakajima N,Saitoh N,Fujimoto S,Nakazato H

    更新日期:2000-05-01 00:00:00

  • Comparative genomics on nemo-like kinase gene.

    abstract::WNT signals are transduced to the planar cell polarity (PCP) pathway or the beta-catenin pathway. Drosophila Frizzled (Fz), Starry night (Stan), Van Gogh (Vang), Dishevelled (Dsh), Prickle (Pk), Diego (Dgo) and Nemo (Nmo) are implicated in the PCP signaling pathway. Choi and Benzer identified Drosophila Nmo in 1994, a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Katoh M,Katoh M

    更新日期:2005-06-01 00:00:00

  • Regulatory effect of the MAFG‑AS1/miR‑150‑5p/MYB axis on the proliferation and migration of breast cancer cells.

    abstract::Long noncoding RNA (lncRNA) MAF BZIP transcription factor G antisense RNA 1 (MAFG‑AS1) has been demonstrated to serve an important role in the progression of various types of cancer, whereas its role in breast cancer has not been fully elucidated. The present study aimed to explore the potential role and underlying me...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.5150

    authors: Jia H,Wu D,Zhang Z,Li S

    更新日期:2020-11-20 00:00:00

  • Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma.

    abstract::Gene amplification is a frequent event in lung cancer, specifically in squamous cell lung carcinoma. Recently, we reported amplifications on chromosomal bands 3q26.1-q26.3 with the genes BCHE and SLC2A2 amplified in 40% of squamous cell lung carcinomas. Here, we identified an amplified domain within chromosomal bands ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.17.1.67

    authors: Rácz A,Brass N,Höfer M,Sybrecht GW,Remberger K,Meese EU

    更新日期:2000-07-01 00:00:00

  • New aromatase inhibitors in the treatment of advanced breast cancer.

    abstract::New aromatase inhibitors are an exciting treatment option for postmenopausal women with hormone sensitive breast cancer. They have been shown to reduce tumors in a significant number of patients, and exhibit definite antitumor activity at a relatively low daily dose, and are highly potent, highly selective, and well-t...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.17.5.1037

    authors: Crucitta E,Lorusso V,Attolico M,Sambiasi D,Mazzei A,De Lena M

    更新日期:2000-11-01 00:00:00

  • Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor.

    abstract::This study evaluated the effects of a combination of opioid growth factor (OGF) and paclitaxel on squamous cell carcinoma of the head and neck (SCCHN) using a tissue culture model of human SCCHN. The combination of OGF and paclitaxel was markedly inhibitory to SCCHN proliferation, reducing growth from control levels b...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: McLaughlin PJ,Jaglowski JR,Verderame MF,Stack BC,Leure-Dupree AE,Zagon IS

    更新日期:2005-03-01 00:00:00

  • Trans-activating activity of the E6 proteins of the human papillomavirus (HPV) type-11 and -16 on the PE1E4 promoter of HPV-11 in C33A cells.

    abstract::We investigated trans-activating effects of the full-length E6 protein of HPV-16 (16E6) and the E6 protein of HPV-11 (11E6) on the PE1E4 promoter of HPV-11 in C33A cells which lack normal function of p53. 16E6 showed no significant activation of the reporter plasmid containing PE1E4 and the upstream sequence, includin...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.6.1253

    authors: Tomita Y,Asano Y,Shirasawa H

    更新日期:1998-12-01 00:00:00

  • The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.

    abstract::The signal transducer and activator of transcription 3 (STAT3) factor plays an important role in the tumorigenicity of cancer stem cells. The purpose of this study was to investigate the inhibitory mechanism of this pathway acting through the tumor suppressor von Hippel-Lindau (VHL) protein in glioma cancer stem cells...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.1773

    authors: Kanno H,Sato H,Yokoyama TA,Yoshizumi T,Yamada S

    更新日期:2013-03-01 00:00:00

  • Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells.

    abstract::The presence of arachidonate 12-lipoxygenase (12-LOX) potentiates prostate cancer (PCa) progression and therefore may be a good therapeutic target and/or a potential diagnostic predictor for PCa. In this study, we examined the expression of 12-LOX in PCa stem cells (PCa SCs) to test if it can serve as a unique marker ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.901

    authors: Yin B,Yang Y,Zhao Z,Zeng Y,Mooney SM,Li M,Xu X,Song Y,Wu B,Yang Z

    更新日期:2011-04-01 00:00:00

  • Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.

    abstract::Rhabdomyosarcoma (RMS) is a malignant tumour of skeletal muscle origin which includes two major histological subtypes: alveolar rhabdomyosarcoma (ARMS), the more aggressive, and embryonal rhabdomyosarcoma (ERMS). In order to establish whether the higher metastatic potential of ARMS cells may depend on differential exp...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Onisto M,Slongo ML,Gregnanin L,Gastaldi T,Carli M,Rosolen A

    更新日期:2005-09-01 00:00:00

  • 5-Caffeoylquinic acid inhibits invasion of non-small cell lung cancer cells through the inactivation of p70S6K and Akt activity: Involvement of p53 in differential regulation of signaling pathways.

    abstract::In the present study, we investigated the effects and molecular mechanism of 5-caffeoylquinic acid (5-CQA), a natural phenolic compound isolated from Ligularia fischeri, on cell invasion, proliferation and adhesion in p53 wild-type A549 and p53-deficient H1299 non-small cell lung cancer (NSCLC) cells. 5-CQA abrogated ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3436

    authors: In JK,Kim JK,Oh JS,Seo DW

    更新日期:2016-05-01 00:00:00

  • Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor.

    abstract::Most malignant tumors have a defect in the Rb pathway that allows them to proliferate autonomously, unrestricted by the availability of mitogens and growth factors. This defect preconditions tumor cells to be less sensitive to inhibitors of growth factor receptors and/or signal transduction pathways that arrest normal...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.4.811

    authors: Du L,Smolewski P,Bedner E,Traganos F,Darzynkiewicz Z

    更新日期:2001-10-01 00:00:00

  • Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells.

    abstract::We have previously shown that the combination of allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT) and donor lymphocyte infusion (DLI) using CD4+ cell-depleted spleen cells is effective in suppressing tumor growth, but that this does not induce graft-versus-host disease (GVHD) in mice. In this report,...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Mukaide H,Adachi Y,Koike-Kiriyama N,Suzuki Y,Minamino K,Iwasaki M,Tsuda M,Nakano K,Koike Y,Shigematsu A,Kamiyama Y,Ikehara S

    更新日期:2007-06-01 00:00:00

  • Enhanced tumorigenic and metastatic potential of an androgen-sensitive human prostate cancer cell line, LNCaP, by intratesticular inoculation in SCID mice.

    abstract::To establish a prostate cancer model expressing prostate-specific antigen (PSA) with metastatic potential, LNCaP or PC-3 cells were inoculated into the testis of SCID mice, resulting in a 100% rate of tumor formation. A significant increase in serum PSA was found in mice with LNCaP xenografts. Circulating tumor cells ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.3.513

    authors: Koshida K,Endo Y,Kobayashi T,Imao T,Konaka H,Kadono Y,Uchibayashi T,Sasaki T,Namiki M

    更新日期:1997-09-01 00:00:00

  • Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.

    abstract::A putative tumor suppressor, PTEN/MMAC1 gene was recently identified at 10q23 and was found to be frequently altered in several types of human tumors. To determine the possible role of this gene in human ovarian tumors, we screened 31 unselected primary epithelial ovarian cancers with matched normal tissues and 7 ovar...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.1.101

    authors: Yokomizo A,Tindall DJ,Hartmann L,Jenkins RB,Smith DI,Liu W

    更新日期:1998-07-01 00:00:00

  • Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.

    abstract::ETS variant 1 (ETV1) is an oncogenic transcription factor. However, its role in colorectal cancer has remained understudied. The present study demonstrated that ETV1 downregulation led to reduced HCT116 colorectal cancer cell growth and clonogenic activity. Furthermore, the ETV1 mRNA levels were enhanced in colorectal...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.5133

    authors: Oh S,Song H,Freeman WM,Shin S,Janknecht R

    更新日期:2020-12-01 00:00:00

  • CD38 is involved in cell energy metabolism via activating the PI3K/AKT/mTOR signaling pathway in cervical cancer cells.

    abstract::In contrast to normal cells, cancer cells typically undergo metabolic reprogramming. Studies have shown that oncogenes play an important role in this metabolic reprogramming. CD38 is a multifunctional transmembrane protein that is expressed abnormally in a variety of tumor types. To investigate the effect and possible...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.5040

    authors: Liao S,Liang L,Yue C,He J,He Z,Jin X,Luo G,Zhou Y

    更新日期:2020-07-01 00:00:00

  • Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review).

    abstract::High lactate production in cells during growth under oxygen-rich conditions (aerobic glycolysis) is a hallmark of tumor cells, indicating the role of mitochondrial function in tumorigenesis. In fact, enhanced mitochondrial biogenesis and impaired quality control are frequently observed in cancer cells. Mitochondrial D...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2018.4468

    authors: Jiménez-Morales S,Pérez-Amado CJ,Langley E,Hidalgo-Miranda A

    更新日期:2018-09-01 00:00:00

  • In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination.

    abstract::Head and neck squamous cell carcinoma (HNSCC) and acute myeloid leukemia are the major causes of mortality and morbidity in Fanconi anemia (FA) patients. The objective of this study was to investigate the antineoplastic activity of PB, an antineoplastic nutrient mixture (containing quercetin, curcumin, green tea, cruc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.2895

    authors: Roomi MW,Kalinovsky T,Roomi NW,Niedzwiecki A,Rath M

    更新日期:2015-05-01 00:00:00

  • Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.

    abstract::Survivin is a member of the inhibitor of apoptosis family, which is known to inhibit mitochondrial apoptosis. Survivin is highly expressed in cancers and plays an important role in cancer cell survival, and increased survivin expression is an unfavorable prognostic marker in cancer patients. YM155, a novel small-molec...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.3077

    authors: Minoda M,Kawamoto T,Ueha T,Kamata E,Morishita M,Harada R,Toda M,Onishi Y,Hara H,Kurosaka M,Akisue T

    更新日期:2015-09-01 00:00:00

  • Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.

    abstract::Malignant astrocytomas are highly invasive, vascular neoplasms that comprise the majority of nervous system tumors in humans. A strong association has previously been made between malignancy in human astrocytic tumors and increased expression of certain fibroblast growth factor (FGF) family members. MG-160 is an intri...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Yamaguchi F,Morrison RS,Gonatas NK,Takahashi H,Sugisaki Y,Teramoto A

    更新日期:2003-05-01 00:00:00

  • KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.

    abstract::Autocrine/paracrine stimulation of KIT has been observed in colorectal carcinoma (CRC) cell lines. We investigated the expression of KIT and stem cell factor (SCF) in CRC in comparison with premalignant colon lesions and normal colonic mucosa to assess the prognostic and therapeutic relevance of this receptor/ligand s...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Bellone G,Smirne C,Carbone A,Buffolino A,Scirelli T,Prati A,Solerio D,Pirisi M,Valente G,Nano M,Emanuelli G

    更新日期:2006-10-01 00:00:00